Conflict of Interest

Jennifer Doudna Disclosures

The Regents of the University of California have patents issued and pending for CRISPR technologies on which J.A.D. is an inventor.

J.A.D. is a cofounder of  Azalea Theratupics, Caribou Biosciences, Editas Medicine, Evercrisp, Scribe Therapeutics, Intellia Therapeutics, and Mammoth BiosciencesJ.A.D. is a scientific advisory board member at Evercrisp, Caribou Biosciences, Intellia Therapeutics, Scribe Therapeutics, Mammoth Biosciences, The Column Group and Inari. She also is an advisor for Aditum Bio.

J.A.D. is Chief Science Advisor to Sixth Street, a Director at Johnson & Johnson, Altos and Tempus, and has a research project sponsored by Apple Tree Partners.